marijuana stocks

Form 8-K for INSYS THERAPEUTICS, INC.


27-Aug-2015

Other Events

Item 8.01 Other Events.On August 26, 2015, Insys Therapeutics, Inc. (the “Company”) received purported service of notice of three inter partes review (“IPR”) petitions filed by a hedge fund with the U.S. Patent and Trademark Office, challenging three of the four Orange Book-listed patents covering Subsys. The Company intends to oppose the request to institute the IPR and, if any of the three petitions are granted, the Company intends to defend the validity of each patent challenged in each IPR.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Innocan Pharma Corporation (INNPF) Provides an Operational Update

Innocan Pharma Provides an Operational Update Innocan Pharma Corporation (CSE: INNO) (FSE:…

$ENRT Form 8-K

Form 8-K for ENERTOPIA CORP. 28-Feb-2017 Unregistered Sale of Equity Securities, Regulation…

GW Pharmaceuticals plc (GWPH) Receives Orphan Drug Designation from the European Medicines Agency

GW Pharmaceuticals Receives Orphan Drug Designation from the European Medicines Agency (EMA)…